Delayed-start analyses of up to 3.5 years in the phase 3 solanezumab expedition program in mild Alzheimer's disease

Liu-Seifert, Hong; Aisen, Paul S; Andersen, Scott W.; Holdridge, Karen C.; Siemers, Eric R.

doi:10.1016/j.jalz.2015.07.338

Record: found
Abstract: not found
Article: not found

Delayed-start analyses of up to 3.5 years in the phase 3 solanezumab expedition program in mild Alzheimer's disease

Author(s): Hong Liu-Seifert , Paul S. Aisen , Scott W. Andersen , Karen C. Holdridge , Eric R. Siemers

Publication date Created: July 2015

Publication date (Print): July 2015

Journal: Alzheimer's & Dementia

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Alzheimer's & Dementia

Abbreviated Title: Alzheimer's & Dementia

Publisher: Elsevier BV

ISSN (Print): 15525260

Publication date Created: July 2015

Publication date (Print): July 2015

Volume: 11

Issue: 7

Pages: P262-P263

Article

DOI: 10.1016/j.jalz.2015.07.338

SO-VID: 01470b41-4e6b-4ad6-9a98-edae1c4cf77b

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

Cited by 3

See all cited by

Delayed-start analyses of up to 3.5 years in the phase 3 solanezumab expedition program in mild Alzheimer's disease

Read this article at

Related collections

50 years of ROAPE

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 2,032

Cited by 3